Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Heron Therapeutics (HRTX) has a market cap of $0.25 billion USD. According to our data, Heron Therapeutics is ranked No.6885 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $0.25 B |
6.54%
|
| Dec 31, 2024 | $0.23 B |
-10.00%
|
| Dec 29, 2023 | $0.26 B |
-32.00%
|
| Dec 30, 2022 | $0.38 B |
-72.62%
|
| Dec 31, 2021 | $1.39 B |
-56.87%
|
| Dec 31, 2020 | $3.22 B |
-9.91%
|
| Dec 31, 2019 | $3.57 B |
-9.41%
|
| Dec 31, 2018 | $3.95 B |
43.31%
|
| Dec 29, 2017 | $2.75 B |
38.17%
|
| Dec 30, 2016 | $1.99 B |
-50.94%
|
| Dec 31, 2015 | $4.06 B |
165.41%
|
| Dec 31, 2014 | $1.53 B |
11.78%
|
| Dec 31, 2013 | $1.37 B |
-18.18%
|
| Dec 31, 2012 | $1.67 B |
139.13%
|
| Dec 30, 2011 | $0.70 B |
-48.89%
|
| Dec 31, 2010 | $1.37 B |
-64.29%
|
| Dec 31, 2009 | $3.83 B |
200.00%
|
| Dec 31, 2008 | $1.28 B |
-73.42%
|
| Dec 31, 2007 | $4.81 B |
-71.17%
|
| Dec 29, 2006 | $16.67 B |
-10.46%
|
| Dec 30, 2005 | $18.62 B |
-7.27%
|
| Dec 31, 2004 | $20.08 B |
-32.65%
|
| Dec 31, 2003 | $29.81 B |
145.00%
|
| Dec 31, 2002 | $12.17 B |
-64.29%
|
| Dec 31, 2001 | $34.07 B |
17.89%
|
| Dec 29, 2000 | $28.90 B |
-30.91%
|
| Dec 31, 1999 | $41.83 B |
-36.05%
|
| Dec 31, 1998 | $65.40 B |
-18.87%
|
| Dec 31, 1997 | $80.61 B |
-13.11%
|
| Dec 31, 1996 | $92.78 B |
38.64%
|
| Dec 29, 1995 | $66.92 B |
25.71%
|
| Dec 30, 1994 | $53.23 B |
-16.67%
|
| Dec 31, 1993 | $63.88 B |
-37.31%
|
| Dec 31, 1992 | $101.90 B |
-20.24%
|
| Dec 31, 1991 | $127.76 B |
366.67%
|
| Dec 31, 1990 | $27.38 B |
-60.87%
|
| Dec 29, 1989 | $69.96 B |
-6.12%
|
| Dec 30, 1988 | $74.53 B |
11.36%
|
| Dec 31, 1987 | $66.92 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Pacira Biosciences
PCRX
|
$1.04 B |
-0.000 M
|
USA
|
 Collegium Pharmaceutical
COLL
|
$1.05 B |
0.000 M
|
USA
|
 Assertio Therapeutics
ASRT
|
$77.34 M |
-0.000 M
|
USA
|
 Trevena
TRVN
|
$1.61 M |
0.000 M
|
USA
|
 Cara Therapeutics
CARA
|
$21.85 M |
0.000 M
|
USA
|
 Nektar Therapeutics
NKTR
|
$0.17 B |
0.000 M
|
USA
|
 Alkermes
ALKS
|
$4.89 B |
-0.000 M
|
Ireland
|
| Market Cap | = | HRTX Stock Price | * | HRTX Shares Outstanding |
| = | $1.63 | * | 0.15 B | |
| = | $0.25 B |